돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 55032생성일: 2026년 10월 24일

2,4-Dichloro-6,7-dimethoxyquinazoline → 3-[1-(2-Chloro-6,7-dimethoxy-4-quinazolinyl)-4-piperidinyl]-1,2,3,4-tetrahydro-1,6-dimethyl-2,4-dioxo-quinazoline

https://huagongshe.com/ko/reaction/55032

반응식

참여 물질

역할이름HCID투입량
반응물2,4-Dichloro-6,7-dimethoxyquinazolineHCID 520327—
반응물1,2,3,4-Tetrahydro-1,6-dimethyl-2,4-dioxo-3-(4-piperidinyl)quinazoline hydrobromideHCID 21851222—
생성물3-[1-(2-Chloro-6,7-dimethoxy-4-quinazolinyl)-4-piperidinyl]-1,2,3,4-tetrahydro-1,6-dimethyl-2,4-dioxo-quinazolineHCID 1543451348%

반응 단계

The procedure similar to that described in Example 40 was repeated, except that 354.0 mg (1.0 mmol) of 1,2,3,4-tetrahydro-1,6-dimethyl-2,4-dioxo-3-(4-piperidinyl)-quinazoline hydrobromide (Compound v) obtained in Example 41 was used and 2,4-dichloro-6,7-dimethoxyquinazoline was used in place of 4-chloro-6,7-dimethoxyquinazoline. As a result, 239.2 mg (yield: 48%) of Compound 78 was obtained as white crystals.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US05624926
출처 데이터셋uspto-grants-1997_04
ORD IDord-771c5b53373c4c84bb41953e46ea8a9a
출처 메모uspto-grants-1997_04